Loading…
Anlon Healthcare (AHCL)₹26.93−3.23%Pharmaceuticals
At the end of the Sep 2026 quarter, Anlon Healthcare's shareholders were: promoters 52.67%, FIIs 0.99%, DIIs 0.30%, public 46.04%. Promoter holding is unchanged on the quarter. FII holding is up 0.99 percentage points from 0.00% a year earlier. 0.00% of promoter shares were pledged. It had 81,362 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|
| Promoters | 52.67% | 52.67% | 52.67% | 52.67% | 52.67% |
| FIIs | 0.00% | 0.23% | 0.32% | 1.68% | 0.99% |
| DIIs | 2.81% | 4.46% | 4.57% | 1.22% | 0.30% |
| Public | 44.52% | 42.64% | 42.44% | 44.43% | 46.04% |
| Promoter shares pledged | — | — | — | — | 0.00% |
| Number of shareholders | 12,465 | 11,413 | 12,485 | 34,674 | 81,362 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Punitkumar R Rasadia | Promoter | 34.95% | 0.00 |
| Meet Atulkumar Vachhani | Promoter | 17.65% | 0.00 |
| Shree Dwarikadhish Ventures Llp | Public | 7.47% | 0.00 |
| Ban Labs Private Limited | Public | 5.28% | 0.00 |
| Jay Mauleshkumar Ukani | Public | 1.14% | 0.00 |
| Luv Natwarlal Ukani | Public | 1.14% | 0.00 |
| Harshad Rasiklal Sheth | Public | 1.00% | −0.12 |
Promoters held 52.67% of Anlon Healthcare at the end of the Sep 2026 quarter, the same as a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 0.99% (down 0.69 percentage points from 1.68% a quarter earlier) and domestic institutions (DIIs) held 0.30% (down 0.92 percentage points from 1.22% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Anlon Healthcare had 81,362 shareholders at the end of the Sep 2026 quarter, against 12,465 a year earlier.
Shree Dwarikadhish Ventures Llp (Public) held 7.47% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.